184 related articles for article (PubMed ID: 30448691)
1. Outcomes and costs of single-step hepatitis C testing in primary care, Birmingham, United Kingdom.
Munang M; Smit E; Barnett T; Atherton C; Tahir M; Atabani SF
Public Health; 2019 Jan; 166():40-44. PubMed ID: 30448691
[TBL] [Abstract][Full Text] [Related]
2. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four mini-pool HCV RNA screening in a routine clinical virology laboratory setting: a six-year prospective study.
Seme K; Mocilnik T; Poljak M
J Virol Methods; 2011 Jan; 171(1):303-5. PubMed ID: 21087636
[TBL] [Abstract][Full Text] [Related]
4. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
Blackburn NA; Patel RC; Zibbell JE
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
[TBL] [Abstract][Full Text] [Related]
5. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.
Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D;
MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252
[TBL] [Abstract][Full Text] [Related]
6. Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis.
Jülicher P; Chulanov VP; Pimenov NN; Chirkova E; Yankina A; Galli C
PLoS One; 2019; 14(7):e0219687. PubMed ID: 31310636
[TBL] [Abstract][Full Text] [Related]
7. Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individuals.
Ward JW
Antivir Ther; 2012; 17(7 Pt B):1397-401. PubMed ID: 23321543
[TBL] [Abstract][Full Text] [Related]
8. The disposition of hepatitis C antibody-positive patients in an urban hospital.
Putka B; Mullen K; Birdi S; Merheb M
J Viral Hepat; 2009 Nov; 16(11):814-21. PubMed ID: 19842281
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.
Ragan K; Pandya A; Holotnak T; Koger K; Collins N; Swain MG
Can J Gastroenterol Hepatol; 2020; 2020():5258289. PubMed ID: 32211349
[TBL] [Abstract][Full Text] [Related]
11. Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens.
Irving WL; Smith S; Cater R; Pugh S; Neal KR; Coupland CA; Ryder SD; Thomson BJ; Pringle M; Bicknell M; Hippisley-Cox J
J Viral Hepat; 2006 Apr; 13(4):264-71. PubMed ID: 16611193
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: results of a 2-year prospective study.
Seme K; Mocilnik T; Fujs K; Babic DZ; Todorović A; Fras-Stefan T; Poljak M
J Virol Methods; 2007 Mar; 140(1-2):218-21. PubMed ID: 17157928
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
[TBL] [Abstract][Full Text] [Related]
14. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C screening strategies in hemodialysis patients.
Saab S; Brezina M; Gitnick G; Martin P; Yee HF
Am J Kidney Dis; 2001 Jul; 38(1):91-7. PubMed ID: 11431187
[TBL] [Abstract][Full Text] [Related]
16. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
[TBL] [Abstract][Full Text] [Related]
17. Changing strategies for hepatitis C testing.
Teo CG
Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup.
Gaudy C; Thevenas C; Tichet J; Mariotte N; Goudeau A; Dubois F
J Clin Microbiol; 2005 Apr; 43(4):1722-6. PubMed ID: 15814991
[TBL] [Abstract][Full Text] [Related]
19. Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring.
Soulier A; Poiteau L; Rosa I; Hézode C; Roudot-Thoraval F; Pawlotsky JM; Chevaliez S
J Infect Dis; 2016 Apr; 213(7):1087-95. PubMed ID: 26333945
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
